Idera Pharmaceuticals Stock Return On Asset
| IDRADelisted Stock | USD 0.43 0.05 10.42% |
Idera Pharmaceuticals fundamentals help investors to digest information that contributes to Idera Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Idera Stock. The fundamental analysis module provides a way to measure Idera Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Idera Pharmaceuticals stock.
Idera |
Idera Pharmaceuticals Company Return On Asset Analysis
Idera Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Idera Pharmaceuticals Return On Asset | -0.15 |
Most of Idera Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Idera Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Idera Pharmaceuticals has a Return On Asset of -0.1519. This is 98.26% lower than that of the Biotechnology sector and 99.36% lower than that of the Health Care industry. The return on asset for all United States stocks is 8.5% higher than that of the company.
Idera Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Idera Pharmaceuticals' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Idera Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Idera Pharmaceuticals by comparing valuation metrics of similar companies.Idera Pharmaceuticals is currently under evaluation in return on asset category among related companies.
Idera Fundamentals
| Return On Equity | -0.32 | |||
| Return On Asset | -0.15 | |||
| Operating Margin | (354.22) % | |||
| Current Valuation | (8.7 M) | |||
| Shares Outstanding | 62.36 M | |||
| Shares Owned By Insiders | 29.55 % | |||
| Shares Owned By Institutions | 5.52 % | |||
| Number Of Shares Shorted | 414.67 K | |||
| Price To Earning | (4.69) X | |||
| Price To Book | 0.84 X | |||
| Price To Sales | 349.95 X | |||
| Gross Profit | (9.25 M) | |||
| EBITDA | 98.12 M | |||
| Net Income | 98.09 M | |||
| Cash And Equivalents | 24.48 M | |||
| Cash Per Share | 0.46 X | |||
| Total Debt | 656 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 5.40 X | |||
| Book Value Per Share | 0.35 X | |||
| Cash Flow From Operations | (24.6 M) | |||
| Short Ratio | 3.14 X | |||
| Earnings Per Share | (0.44) X | |||
| Target Price | 1.0 | |||
| Number Of Employees | 13 | |||
| Beta | 1.3 | |||
| Market Capitalization | 33.79 M | |||
| Total Asset | 34.86 M | |||
| Retained Earnings | (777.8 M) | |||
| Working Capital | 47.61 M | |||
| Current Asset | 55.47 M | |||
| Current Liabilities | 7.86 M | |||
| Z Score | 7.6 | |||
| Net Asset | 34.86 M |
About Idera Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Idera Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Idera Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Idera Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Idera Stock
If you are still planning to invest in Idera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Idera Pharmaceuticals' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |